Ashjian Emily, Salamin Louise B, Eschenburg Katie, Kraft Shawna, Mackler Emily
J Am Pharm Assoc (2003). 2015 Sep-Oct;55(5):540-5. doi: 10.1331/JAPhA.2015.14214.
To determine the number of discrepancies and medication-related problems found as a result of pharmacy-led medication reconciliation involving introductory pharmacy practice experience (IPPE) students at a comprehensive cancer center.
Outpatient infusion center of a National Cancer Institute (NCI)-designated and National Comprehensive Cancer Network (NCCN) cancer center.
Third-year IPPE students contacted and completed medication reconciliation for 510 hematology/oncology patients scheduled for infusion center appointments without a coupled provider visit. IPPE students discussed the findings of the medication reconciliations with their pharmacist preceptors, who updated the medication histories in the electronic medical record (EMR) and communicated with prescribers directly about identified medication-related problems. All medication reconciliation was documented using a standardized note template in the EMR.
Number of medication discrepancies found, including medication additions, medication deletions, dose changes, and herbal product additions; medication-related problems-including drug-drug interactions, untreated indications (e.g., nausea, vomiting, pain, need for prophylactic medications), failure of patients to receive prescribed medications, and adverse drug reactions-were also documented.
Medication reconciliation was completed for 510 patients through the student pharmacist/pharmacist preceptor-led intervention during a 1-year period between January 1, 2013, and December 31, 2013. A total of 88% of patients had at least one discrepancy identified in their medication history and corrected in the EMR. In addition, 11.4% of patients had a medication-related problem identified.
Pharmacy-led medication reconciliation identified a large number of discrepancies among our hematology/oncology patients. This intervention allowed for correction of discrepancies in the EMR leading to improved accuracy of patient medication lists. In addition, it provided a valuable learning experience for student pharmacists.
确定在一家综合癌症中心,由药学专业学生主导的用药核对工作所发现的差异数量及与用药相关的问题,这些学生参与了基础药学实践经验(IPPE)项目。
一家由美国国立癌症研究所(NCI)指定且属于美国国立综合癌症网络(NCCN)的癌症中心的门诊输液中心。
三年级IPPE学生联系并完成了510名计划在输液中心就诊且未同时看诊医生的血液学/肿瘤学患者的用药核对工作。IPPE学生与他们的带教药师讨论用药核对的结果,带教药师更新电子病历(EMR)中的用药史,并就所发现的与用药相关的问题直接与开处方的医生沟通。所有用药核对均使用EMR中的标准化记录模板进行记录。
发现的用药差异数量,包括用药增加、用药删减、剂量变化以及草药产品添加;还记录了与用药相关的问题,包括药物相互作用、未治疗的适应症(如恶心、呕吐、疼痛、预防性用药需求)、患者未按处方用药以及药物不良反应。
在2013年1月1日至2013年12月31日的1年期间,通过学生药师/带教药师主导的干预,完成了510名患者的用药核对。共有88%的患者在用药史中至少发现一处差异并在EMR中得到纠正。此外,11.4%的患者被发现存在与用药相关的问题。
由药学主导的用药核对在我们的血液学/肿瘤学患者中发现了大量差异。这种干预使得EMR中的差异得以纠正,提高了患者用药清单的准确性。此外它为学生药师提供了宝贵的学习经验。